Check out the beautiful original art created by Dr. Yangzi Isabel Tian for the Nov 6 cover of @CellStemCell with early results from our #ClinicalTrial for RPE replacement to treat dry age-related #MacularDegeneration.
Full Text | https://t.co/LNTh6kg4om
@isabel91775
How close are we to using stem cell treatments for age-related macular degeneration (AMD)?
Join our Macular Chat tomorrow, October 29, with Dr. Jeffrey Stern, co-founder of @NeuralStemCells. He'll cover the latest science, share clinical trial updates, and explain what these advances mean for people living with AMD.
Listen live: https://t.co/u6TK5TyYPQ ππ
They'll break down the science, share clinical trial updates, and explain what these advances mean for people living with AMD.
Register today and ask your questions live: https://t.co/qDkMOPNJYx
Stem cell research is opening new doors for treating age-related #MacularDegeneration (AMD), a leading cause of vision loss.
Join our co-founders, Drs. Jeffrey Stern and Sally Temple on @BrightFocus Foundation's Macular Chat on Wed, Oct 29.
Less than two weeks left to register for the inaugural conference on Assembloids & Complex Cell-Cell Interactions @CSHL
Check out the topics and amazing lineup of speakers! π
A great piece by our friends at Michigan Medicine! We are grateful to have our first clinical trial in the skilled hands of Drs. Rajesh Rao of Kellogg Eye Center, David Liao of LA Retina and Theodore Leng of Stanford Medicine.
Article | https://t.co/ujc9Pop7b4
π Are you a detail-oriented PhD scientist with cell biology or #biomanufacturing experience? Interested in development of a novel clinical stage cell replacement therapy for dry age-related #MacularDegeneration (AMD)? We are #hiring!
Learn more: https://t.co/2PP4uXg8TH
Today, Liz Fisher presents "PLD3 contributions to vascular dysfunction in the context of AD" during the poster session at #AAIC2025!
Poster | #107171
Time | 7:30AM β 4:15PM
Where | Exhibit Hall
Today at #AAIC2025: Taylor Bertucci presents "APOE4 alters vascular cells in cognitively normal brains and in vitro models revealing early pathogenic AD contributions of endothelial cells."
Session | Dissecting molecular disease mechanisms
Time | 2:00 β 3:30PM
Location | Hall G
Coming up at #AAIC2025, Taylor Bertucci and Liz Fisher will present data related to APOE and PLD3 contributions to vascular dysfunction in #Alzheimers Disease. Check it out!
Alzheimer's Association | https://t.co/qcCGgEsTeG
@RepPaulTonko, we were delighted to discuss our work with you today! We deeply appreciate your advocacy in support of our shared goal - to improve healthcare for patients & develop cures for Alzheimer's Disease, Macular Degeneration and other neurodegenerative conditions.
Today, I stopped by @NeuralStemCells new facility in Albany to learn more about how NIH grants are helping this small, nonprofit institution perform groundbreaking research and develop new therapies for neurodegenerative conditions like Alzheimerβs disease.
We were thrilled to host Dr. Kristen Brennand of @Yale this week! She gave a terrific talk on "Using Stem Cells to Explore the Genetics Underlying Brain Disease."
#Schizophrenia#Autism#StemCells
@kristenbrennand
What a week! Many thanks to the #ARVO2025 organizers for a terrific meeting! We loved spending time with great colleagues, catching up with old friends and hearing about so much inspiring #VisionResearch π in beautiful #SaltLakeCity.
@ARVOinfo
Today! Jeff Stern presents "Safety & Tolerability of RPE Stem Cell-derived RPE Implantation in Patients with Dry Age-related #MacularDegeneration: Early Low Dose Clinical Outcomes"
Session Info
Clinical advances in cell & gene therapy
8:30 - 10:15 AM
Ballroom B
#ARVO2025
Today @ #ARVO2025: Brigitte Arduini will present "Preclinical safety and efficacy of an adult progenitor cell product, RPESC-RPE-4W, as therapy for dry Age-Related #MacularDegeneration"
Session Info
Title | Stem cell and gene therapy
Time | 3:15 - 5pm (talk @ 3:15pm)
Room | 255E